CIK 0001137883
- Non-accelerated filer
- Smaller reporting company
BRAINSTORM CELL THERAPEUTICS INC.
Sign in to watch- Ticker
- BCLI
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 207273918
- Phone
- +1 201-488-0460
- Business address
- 1325 AVENUE OF AMERICAS, 28TH FLOOR, NEW YORK, NY, 10019
- Former names
- BRAINSTORM CELL THERAPEUTICS INC, GOLDEN HAND RESOURCES INC, WIZBANG TECHNOLOGIES INC
- 4 Derivatives Options or other derivatives
- 4 Grant or award See Remarks acquired 35,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Chief Executive Officer acquired 31,185 shares (grant or award)
- 4 Open-market buy Director bought 46,779 shares at $12.99 ($607,659)
- 4 Open-market buy EVP and COO bought 5,000 shares at $12.95 ($64,740)
- 4 Open-market sale Member of 10% owner group sold 71,753 shares at an average $13.39 ($960,656)
- 4 Grant or award EVP & Chief Business Officer acquired 10,000 shares (grant or award)
- 4 Grant or award EVP, Head Global Clin Research acquired 25,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award EVP and COO acquired 50,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 4,657 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Grant or award COO and Chief Medical Officer acquired 35,885 shares (grant or award)
- 4 Grant or award Director acquired 5,071 shares (grant or award)
- 4 Grant or award Director acquired 2,000 shares (grant or award)
Page 5 of 17 · 329 filings